<DOC>
	<DOCNO>NCT02613780</DOCNO>
	<brief_summary>Keratoconus bilateral , progressive corneal degenerative disorder often lead significant visual deterioration time . Corneal collagen crosslinking riboflavin ( CXL ) develop treatment halt progression keratoconus thus negate need corneal transplantation . However , treatment alone little impact term improve visual function . Photorefractive keratectomy ( PRK ) application excimer laser treat patient 's refractive error , therefore decrease dependence spectacle contact lenses improved vision . Corneal collagen crosslinking combine photorefractive keratectomy explore partially correct refractive error keratoconic patient , whilst simultaneously stabilize corneal change . Recently , iDesign® Advanced WaveScan Studio ( iDesign system ; Abbot Medical Optics ; Santa Ana , CA ) launch advanced high-resolution aberrometer . It capable map highly aberrate corneas wavefront-guided laser procedure , represent important technological advance treat corneal disease . The purpose single center , prospective pilot study assess safety efficacy combine wavefront-guided PRK CXL patient early keratoconus use iDesign® aberrometer . Results pilot study use provide sample size estimate extension study , aim determine whether sequential day procedure lead good outcome .</brief_summary>
	<brief_title>Refractive Treatment Early Keratoconus</brief_title>
	<detailed_description>The purpose pilot study assess visual outcome combine wavefront-guided PRK CXL Krumeich stage 1 2 keratoconic eye . The investigator conduct prospective study University Ottawa Eye Institute . A total 24 patient enrol study divide two group : Group 1 : PRK performed12-18 month CXL ; Group 2 : PRK perform day CXL Participants follow regular interval 1 year information regard visual , refractive , keratometric high order aberration outcomes collect . The researcher aim investigate safety efficacy combine wavefront guide PRK CXL . Results pilot study use provide estimate sample size calculation extension study , aim determine whether sequential day procedure lead good outcome .</detailed_description>
	<mesh_term>Keratoconus</mesh_term>
	<criteria>Group 1 : 1 . Patients confirm diagnosis keratoconus Krumeich stage 1 2 receive crosslinking 1218 month prior , follow least 12 month Group 2 : 1 . Diagnosis keratoconus confirm base clinical examination finding corneal topography 2 . Evidence progression keratoconus occur last 12 month define : . An increase maximum keratometry read 1 diopter ( ≥ 1 D ) , ii . Evidence clinical progression 3 . Age 21 60 year 4 . Eyes satisfy Krumeich stage 1 2 criterion list . Stage 1 : eccentric corneal bulging , myopia , and/or astigmatism &lt; 5 D corneal radius ≤48 D , corneal opacity ii . Stage 2 : myopia and/or astigmatism &gt; 5 D &lt; 8 D and/or corneal radius ≤53 D , central opacity , pachymetry ≥400 μm 1 . Age le 21 year , old 60 year 2 . Pregnant , plan become pregnant , breastfeed 3 . Past history Herpes Simplex Keratitis corneal surgery ( crosslinking ) 4 . Thin Cornea ( &lt; 425 micron ) 5 . Other corneal disease , corneal scar 6 . History chemical burn cornea know heal problem 7 . Known allergy Riboflavin ( vitamin B2 ) 8 . If patient suffers nystagmus condition would render difficult patient hold steady gaze 9 . Very advanced corneal ectasia ( beyond Krumeich stage 2 ) 10 . Poor visual potential 11 . Vitamin C supplement within 1 week procedure 12 . Lenticular change ( cataract ) 13 . Programmed PRK treatment exceed 50 micron tissue depth</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>